Home/Amphix Bio/Charlotte Chen, PhD
CC

Charlotte Chen, PhD

Principal Scientist

Amphix Bio

Amphix Bio Pipeline

DrugIndicationPhase
AMFX-200SAcute Spinal Cord InjuryPreclinical
AMFX-200Chronic Spinal Cord Injury, Ischemic Stroke, ALS, Parkinson's Disease, NeuropathyDiscovery/Preclinical
AMFX-100Degenerative Disc DiseaseDiscovery/Preclinical
Undisclosed MusculoskeletalArticular Cartilage InjuryDiscovery/Preclinical